Mounjaro Free Samples: What's Real vs. What's a Scam

Is there really such a thing as a free Mounjaro sample? (the honest answer)

Not as an ongoing program, no. If you've seen an ad or a TikTok promising a free box of Mounjaro just for signing up, that offer isn't coming from Eli Lilly. The company has said this in writing: in an open letter addressing counterfeit and misrepresented products, Lilly states plainly that it never sells genuine Mounjaro or Zepbound on social media, and that any tirzepatide product marketed that way — sample, trial, or otherwise — isn't something the company made or approved.

That doesn't mean every path to $0 is fake. It means the real ones look nothing like a free sample. Eli Lilly does run a formal, income-based charitable assistance program, and it does run a savings card that can bring your out-of-pocket cost close to nothing if you're commercially insured. Both require paperwork, eligibility checks, and a prescription — a genuine assistance program screens you in, rather than handing product to anyone who fills out a form on a landing page. The rest of this page walks through exactly what those real programs cover, then flags the specific red flags that separate a legitimate coupon from a scam.

The Mounjaro Savings Card: what it actually covers and who qualifies

This is the closest thing to "free" that most commercially insured patients can actually get, and it's a real Eli Lilly program, not a third-party gimmick. The card has two tiers, and which one applies to you comes down to a single question: does your insurance plan already cover Mounjaro?

• If your plan covers Mounjaro for type 2 diabetes: you can pay as little as $25 for a one-, two-, or three-month fill, with Lilly's contribution capped at $150, $300, or $450 a month depending on the fill length, and $1,950 total for the year.
• If your plan doesn't cover Mounjaro: the card still helps, dropping your cost to as low as $499 for a one-month fill, with up to $647 a month in savings and an $8,411 annual cap.
• Not eligible either way: Medicare, Medicaid, TRICARE, VA, DoD, or any other government-funded insurance — a standard federal restriction on manufacturer coupons, not a Lilly-specific rule.
• Also required: the prescription has to match Mounjaro's FDA-approved use. A chart that documents weight management instead of type 2 diabetes disqualifies you from either tier, even if you also happen to have diabetes.

Both tiers cap out at 13 fills a year, and the current card expires December 31, 2026. Lilly has renewed these programs annually in the past, so a fresh version for the following year is the likely outcome rather than the program simply ending.

Lilly Cares Foundation: the real path to $0 Mounjaro

For patients who are uninsured rather than under-covered, the savings card has nothing to discount — there's no underlying benefit for it to attach to. That's the gap Lilly Cares Foundation, Eli Lilly's charitable patient-assistance arm, is built to fill. Historically, it has provided a free 12-month supply of Mounjaro to patients who are uninsured, have an active type 2 diabetes prescription, and have household income at or below roughly 400% of the federal poverty level — cited as $63,840 a year for a single person under the guidelines that took effect in January 2026 by some sources, though other checks put the figure closer to $62,600. Applications go through lillycares.com or by phone, with your prescriber completing part of the form alongside you.

Here's the honest caveat this section needs: while several sources describe Lilly Cares as currently covering Mounjaro, other recent research turned up conflicting information suggesting Mounjaro, Zepbound, and the newer insulin Rezvoglar may not be on the foundation's current covered-medication list, with older Lilly diabetes drugs like Trulicity and its insulin lineup listed instead. That's a meaningful enough discrepancy that you shouldn't take either version on faith. Call Lilly Cares directly at 1-800-545-6962, or check the current medication list at lillycares.com, before you build a plan around this program.

Red flags: fake "free Mounjaro sample" offers and coupon scams

Demand for GLP-1 drugs has pulled real fraud into the same search results and social feeds as legitimate programs. Cybersecurity researchers at McAfee documented a 183% jump in scam activity tied to weight-loss and diabetes drugs like Ozempic, Mounjaro, and Wegovy in early 2024, and reporting since has described the same pattern continuing: sellers on Instagram, TikTok, Facebook Marketplace, and Craigslist who claim to ship real product, take payment through apps like Zelle, Venmo, or PayPal, and never deliver anything at all.

• No prescription or clinician evaluation required. A real Mounjaro fill — free, discounted, or full price — always requires a valid prescription. A seller skipping that step isn't operating legally.
• Payment only through a peer-to-peer app. Zelle, Venmo, and PayPal transfers to an individual, rather than a licensed pharmacy checkout, are difficult to reverse and are the exact pattern researchers have flagged in these scams.
• "Tirzepatide sodium" or "tirzepatide acetate" on the label. The FDA has stated it isn't aware of a lawful basis for compounding these unapproved salt forms — they're a different active ingredient from the tirzepatide in real Mounjaro or Zepbound, not a generic equivalent.
• "Research use only" or "not for human consumption" language. Lilly's own open letter warns that this labeling signals the product wasn't made to pharmaceutical-grade standards, regardless of how it's marketed.
• Sold on social media at all. Lilly has stated directly that it never sells genuine Mounjaro or Zepbound through social platforms — any offer there is counterfeit, diverted, or simply fake.
• A seller who won't name the licensed pharmacy filling the order. A legitimate compounding pharmacy or telehealth provider will tell you exactly who's dispensing your medication if you ask.

If you're ever unsure whether you've received a counterfeit or unsafe product, Eli Lilly's own guidance is to contact your healthcare provider and report it to your state's Board of Pharmacy — not to keep using it while you figure it out.

No insurance and don't qualify for Lilly Cares — what's the real cheapest path?

This is the gap a lot of women land in: no commercial insurance for the savings card to attach to, and either an off-label weight-loss prescription or an income just above the Lilly Cares threshold. The honest answer is that Mounjaro, specifically, has no self-pay vial program of its own — Eli Lilly built that infrastructure under the Zepbound name instead, since Zepbound carries the weight-management approval most cash-pay patients are actually chasing. Mounjaro and Zepbound are the same molecule, tirzepatide, made by the same company, at the same dose strengths.

Through LillyDirect, self-pay Zepbound vials run $299 a month at the 2.5mg starting dose, $399 at 5mg, and $449 from 7.5mg through 15mg, as long as you refill within 45 days of your last delivery. Miss that window and the price resets to a meaningfully higher rate — different pricing checks put the reset ladder anywhere from roughly $500 up to just over $1,000 at the highest dose tier, so it's worth confirming the current, exact numbers directly at lilly.com/lillydirect/zepbound before you rely on a specific figure.

Below that, compounded tirzepatide through a telehealth provider goes lower still, though it sits on narrower legal footing since the FDA-declared shortage that once justified broad compounding ended in 2024. Providers like Mochi Health, Henry Meds, and Fridays currently price compounded tirzepatide well under LillyDirect's self-pay tiers — see the full compounded Mounjaro breakdown for what each one actually charges and what the current legal status looks like.

GoodRx and other coupon sites: do they beat the official programs?

Worth a quick check, but temper your expectations. GoodRx is known for slashing generic drug prices, and a lot of people assume it does the same thing here — it doesn't, because Mounjaro is still under patent, and Lilly's contracts with the pharmacy-benefit middlemen behind discount cards leave little room for a real cut. Recent pricing checks put GoodRx running somewhere between roughly $990 and $1,160 a month for Mounjaro depending on date and pharmacy — not far under the roughly $1,080 retail list price, and worth pulling a live quote for your own ZIP code rather than assuming one number.

And you can't stack it with anything else on this page. GoodRx is a cash-price coupon you use instead of insurance, not alongside the manufacturer savings card. If your plan covers Mounjaro at all, the savings card will beat GoodRx by a wide margin. Treat GoodRx as a fallback to price-check against LillyDirect or a compounded provider, not as your first move.

Does the savings card or Lilly Cares work if Mounjaro is prescribed for weight loss?

No, and this is the tension a lot of women in perimenopause run into directly. Some prescribers write Mounjaro off-label for weight management, often when metabolic shifts tied to changing estrogen make it a genuinely reasonable option — but neither the savings card nor Lilly Cares checks against your actual goal. Both check the diagnosis code your prescriber submits, and both are built around Mounjaro's single FDA-approved use: type 2 diabetes. A prescription documented as weight management, even for a patient who also has diabetes, falls outside what either program is designed to cover.

If weight management genuinely is the goal, the more honest route is asking your prescriber about Zepbound instead — same molecule, but with the obesity indication that opens up its own savings card, its own LillyDirect self-pay tiers, and, for some commercial plans, actual insurance coverage. Our tirzepatide savings card breakdown covers exactly how the Zepbound and Mounjaro coupons differ and why they can't substitute for each other.

Annual savings math: what each program is really worth over a year

• Mounjaro Savings Card, insured and covered: roughly $300/year out of pocket ($25 x 12), against a $1,950/year total savings cap.
• Mounjaro Savings Card, insured but not covered: roughly $5,988/year ($499 x 12), against an $8,411/year cap.
• Lilly Cares Foundation, if eligible: $0/year for a 12-month supply — confirm current formulary status first.
• LillyDirect Zepbound self-pay, starting dose: roughly $3,588/year ($299 x 12).
• LillyDirect Zepbound self-pay, maintenance dose: roughly $5,388/year ($449 x 12).
• GoodRx coupon: roughly $11,880 to $13,920/year ($990-$1,160 x 12).
• Retail, no discount at all: roughly $12,960/year ($1,080 x 12).

Laid out this way, the gap between the covered savings-card tier and full retail runs past $12,000 a year — the single biggest lever on this page, if your insurance and diagnosis qualify you for it. Knowing which bracket you're actually in, rather than assuming the worst or chasing an offer that sounds too good to check, is what actually moves the number.